Pharmaceutical company Sinclair has announced that Ellansé is now part of Harley Academy’s new education framework.
As the manufacturer of Ellansé, Sinclair shares that the inclusion of Ellansé marks the first biostimulator to be featured in Harley Academy’s Global Evidence Matrix (GEM), a digital education framework providing evidence-based guidance to support safe and effective biostimulatory treatments.
According to Sinclair, Ellansé is a collagen-stimulating dermal filler composed of polycaprolactone (PCL) microspheres suspended in a carboxymethyl cellulose (CMC) gel carrier, which delivers both immediate volumisation and long-term collagen stimulation.
Dr Tristan Mehta, founder and CEO at Harley Academy, said, “Biostimulatory injectables represent the next generation of aesthetic treatments, offering patients both immediate and long-term improvements through collagen stimulation. By incorporating Ellansé into GEM, we are equipping Harley Academy students and app subscribers with clear, evidence-based guidance to deliver these treatments safely and effectively, regardless of experience level.”
